We are live on ! Find out more
ITCI

Intra-Cellular Therapies Inc.
ITCI

Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

132 hedge funds and large institutions have $1.53B invested in Intra-Cellular Therapies Inc. in 2015 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 51 increasing their positions, 38 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more capital invested

Capital invested by funds: $1.11B → $1.53B (+$419M)

34% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 38

18% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 22

3% more funds holding

Funds holding: 128 → 132 (+4)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

65% less call options, than puts

Call options by funds: $5.66M | Put options by funds: $16.4M

Holders
132
Holders Change
+4
Holders Change %
+3.13%
% of All Funds
3.46%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
26
Increased
51
Reduced
38
Closed
22
Calls
$5.66M
Puts
$16.4M
Net Calls
-$10.7M
Net Calls Change
-$15.4M

Top Buyers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
+$43.2M
2
Millennium Management
Millennium Management
New York
+$22.9M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$22.1M
4
FCM
Frontier Capital Management
Massachusetts
+$15.6M
5
TCM
TimesSquare Capital Management
New York
+$11M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$18.8M
2
HCMT
Highland Capital Management (Texas)
Texas
-$17.4M
3
WA
Wasatch Advisors
Utah
-$14.9M
4
RCM
RA Capital Management
Massachusetts
-$12.6M
5
Morgan Stanley
Morgan Stanley
New York
-$10.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
CCP
26
Clough Capital Partners
Massachusetts
$11.2M -$3.55M -70,400 -25%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$10.4M +$1.28M +25,312 +15%
TCM
28
Tekla Capital Management
Massachusetts
$10.1M +$1.91M +37,800 +25%
Lord, Abbett & Co
29
Lord, Abbett & Co
New Jersey
$10M +$2.52M +49,914 +37%
RSCM
30
Rock Springs Capital Management
Maryland
$9.68M – – –
Bank of New York Mellon
31
Bank of New York Mellon
New York
$9.04M +$1.64M +32,470 +24%
Point72 Asset Management
32
Point72 Asset Management
Connecticut
$8.83M +$7.06M +139,900 +576%
Allianz Asset Management
33
Allianz Asset Management
Germany
$8.79M -$1.46M -28,902 -15%
BIM
34
BlackRock Investment Management
Delaware
$8.4M +$530K +10,502 +7%
Invesco
35
Invesco
Georgia
$7.36M +$327K +6,486 +5%
CS
36
Candriam SCA
Luxembourg
$7.33M +$1.01M +20,000 +17%
RPAM
37
Rhenman & Partners Asset Management
Sweden
$6.78M -$1.97M -39,000 -24%
CWG
38
C WorldWide Group
Denmark
$6.67M +$6.25M +124,000 New
WMSA
39
Weiss Multi-Strategy Advisers
New York
$6.13M – – –
TCIM
40
TIAA CREF Investment Management
New York
$5.93M +$1.12M +22,284 +25%
EI
41
EAM Investors
California
$5.71M +$559K +11,075 +12%
DCM
42
Driehaus Capital Management
Illinois
$5.55M +$736K +14,586 +16%
BlackRock
43
BlackRock
New York
$5.46M -$731K -14,488 -12%
Charles Schwab
44
Charles Schwab
California
$5.12M +$1.53M +30,279 +47%
WRF
45
Waddell & Reed Financial
Kansas
$4.95M -$1.76M -34,800 -27%
SEI Investments
46
SEI Investments
Pennsylvania
$4.54M +$4.26M +84,389 New
CCM
47
Cupps Capital Management
Illinois
$4.27M +$4M +79,324 New
California Public Employees Retirement System
48
California Public Employees Retirement System
California
$4.23M +$3.31M +65,700 +505%
TAM
49
Tocqueville Asset Management
New York
$4.15M +$525K +10,400 +16%
State of New Jersey Common Pension Fund D
50
State of New Jersey Common Pension Fund D
New Jersey
$3.36M – – –
1
2
3 4 5

ITCI Hedge Fund Activity: Q4 2015 in Review

132 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Intra-Cellular Therapies Inc. (ITCI) for Q4 2015, worth a combined $1.53B — up 38% from $1.11B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new ITCI positions and 22 closed out — a net gain of 4 holders — while 51 added to existing stakes and 38 trimmed.

The largest buyer was Jennison Associates, adding an estimated $43.2M. The largest seller was State Street, cutting an estimated $18.8M.

  • 132 institutional investors held Intra-Cellular Therapies Inc. (ITCI) as of Q4 2015, up from 128 in Q3 2015.
  • Funds reported $1.53B of Intra-Cellular Therapies Inc. stock for Q4 2015, up 38% quarter-over-quarter.
  • 26 funds opened new Intra-Cellular Therapies Inc. positions in Q4 2015 and 22 closed out, a net change of +4 holders.
  • The largest Intra-Cellular Therapies Inc. buyer in Q4 2015 was Jennison Associates, an estimated $43.2M added.
  • The largest Intra-Cellular Therapies Inc. seller in Q4 2015 was State Street, an estimated $18.8M sold.

Based on aggregated 13F filings for Q4 2015.